Online first
Research Letter
Published online: 2024-10-29
Pregabalin and gabapentin-induced heart failure
DOI: 10.5603/cj.98754
Pubmed: 39470187
Abstract
Not available
References
- Page RL, Cantu M, Lindenfeld J, et al. Possible heart failure exacerbation associated with pregabalin: case discussion and literature review. J Cardiovasc Med (Hagerstown). 2008; 9(9): 922–925.
- Fong T, Lee A. Pregabalin-Associated Heart Failure Decompensation in a Patient With a History of Stage I Heart Failure. Annals of Pharmacotherapy. 2014; 48(8): 1077–1081.
- Pan Y, Davis PB, Kaebler DC, et al. Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. Cardiovasc Diabetol. 2022; 21(1): 170.
- Largeau B, Bordy R, Pasqualin C, et al. Gabapentinoid-induced peripheral edema and acute heart failure: A translational study combining pharmacovigilance data and in vitro animal experiments. Biomedicine & Pharmacotherapy. 2022; 149: 112807.
- Wynn E, Biskupiak J, Kim K, et al. Pregabalin Does Not Increase Risk of Heart Failure Exacerbation in Patients With Pre-existing Heart Failure. Ann Pharmacother. 2024; 58(1): 15–20.
- Wynn E, Biskupiak J, Kim K, et al. Abstract 11912: Pregabalin Use Increases the Risk of Acute Heart Failure in Patients With Heart Failure: A Population-Based Study. Circulation. 2022; 146(Suppl_1).
- Lund M, Poulsen G, Pasternak B, et al. Use of Pregabalin and Worsening Heart Failure: A Nationwide Cohort Study. Drug Saf. 2020; 43(10): 1035–1044.
- Ho JMW, Macdonald EM, Luo J, et al. Pregabalin and heart failure: A population-based study. Pharmacoepidemiol Drug Saf. 2017; 26(9): 1087–1092.
- Awwad Z, El-Ganainy S, ElMallah A, et al. Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1–7. Cardiovascular Toxicology. 2019; 20(3): 301–311.
- Kanugula AK, Kaur J, Batra J, et al. Renin-Angiotensin System: Updated Understanding and Role in Physiological and Pathophysiological States. Cureus. 2023; 15(6): e40725.
